Aim Resources used in surveillance colonoscopies are taking up an increasing proportion of colonoscopy capacity. Colon capsule endoscopy (CCE) is a promising technique for noninvasive investigation of the colon. We aimed to investigate CCE as a possible filter in colonic surveillance with the primary outcome of reducing the number of colonoscopies.
Introduction
Surveillance colonoscopies are taking up a large proportion of colonoscopy capacity. The two primary indications are personal history of colorectal adenomas or familial history of colorectal cancer (CRC). The rationale for surveillance is the increased risk of developing CRC within these groups [1, 2] . With the onset of CRC screening, surveillance colonoscopies are expected to account for up to 50% of screening-derived colonoscopies [3, 4] . As colonoscopy capacity is limited, the means to achieve adequate surveillance and reduce demand for colonoscopy are sought. Colon capsule endoscopy (CCE) is a minimally invasive technique for investigation of the colon. In a small study of 62 individuals with positive results from faecal test screening Holleran et al. [5] concluded that CCE could be a useful 'filter test' to colonoscopy and reduce demand for colonoscopy by 71%. Spada et al. [6] published a review and meta-analyses of the diagnostic accuracy of secondgeneration CCE compared with colonoscopy in 2016. For polyps ≥ 10 mm they found a per-patient sensitivity of 87% and a specificity of 95.3%. Since then two larger-scale studies have been published which found similar results. Parodi et al. [7] reported a sensitivity of 89% and a specificity of 95% for polyps ≥ 10 mm, and for CCE we found a per-patient sensitivity and specificity for polyps ≥ 10 mm of 87% and 92%, respectively. In complete CCE exams we found a sensitivity of 93% in detecting individuals at increased risk who required colonoscopy for polyp removal, using a threshold of more than two polyps or at least one polyp > 10 mm [8] . In this light, CCE seems a lenient method for use as a filter-test in colonic surveillance if the aim is to reduce the number of scheduled colonoscopies. The ability to accurately discriminate between those requiring a colonoscopy and those who don't is of paramount importance if CCE is to be used as a filter test. To date, all studies on the colon capsule have focused on the diagnostic accuracy of CCE compared with colonoscopy with the performance of blinded procedures. No trials have investigated the effect of CCE as an actual filter to unblinded colonoscopy.
The aim of this study was to investigate the short term clinical consequences of using CCE as a filter test before an unblinded surveillance colonoscopy, with the reduction in colonoscopies as the primary outcome.
Method
The patients included came from a prospective randomized trial evaluating three different booster regimens for CCE. The primary end-point was completion rate and no significant differences were found between the regimens used [9] .
Inclusion criteria were patients aged 18-70 years scheduled for surveillance colonoscopy between 1 February 2017 and 1 November 2017 and who had at least one additional colonoscopy planned within the next 5 years regardless of the result of the current investigation. Exclusion criteria were a history of previous bowel resection, known gastrointestinal strictures, inflammatory bowel disease, renal insufficiency, implanted electronic devices, pregnancy, breast feeding, allergy towards active preparation and booster substances and familial adenomatous polyposis. Participants were prepared with a 2-l split dose of polyethylene glycol preparation then swallowed the PillCam Colon II (Medtronic, Minneapolis, Minnesota, USA) and received one of the three booster regimens. The CCE video recordings were read by trained personnel (Corporate Healthâ, Hamburg, Germany). The reports contained information on the extent of colon visualized and the grade of bowel cleanliness (1-4) [10] ; any suspicious lesions were documented by still images together with the estimated location (right, transverse, left colon and rectum). The size of polyps was measured in mm. Analyses of the video recordings were done using the RAPID READERâ software (Medtronic). All participants with either inadequate bowel cleansing or an incomplete video due to slow transit underwent supplemental endoscopy to investigate the parts of the colon not visualized by CCE. Participants with hereditary nonpolyposis colorectal cancer (HNPCC) who had any polyp found on CCE were referred for therapeutic endoscopy. All other participants were only referred for endoscopy if there were more than two polyps (irrespective of polyp size) or one polyp > 9 mm. The endoscopists were aware of the CCE findings and endoscopies were carried out to the extent necessary to retrieve the suspected findings and to investigate the parts of the colon not sufficiently visualized by the capsule.
The CCE examination was regarded as complete when a complete video recording of the colon and rectum with adequate cleansing (grade ≥ 2) was achieved. Clinical outcome parameters included the number of participants referred for endoscopy after CCE, the polyp findings and risk stratification according to the European Society of Gastroenterology guidelines [3] . We compared the polyp findings by CCE and colonoscopy in the patients who had a complete CCE and underwent full colonoscopy. The polyp findings by CCE and colonoscopy were matched using a best-fit first approach matching polyps within a 50% size range of the CCE and colonoscopy measure, and a location in the same or adjacent colonic segment (right, transverse, left colon and rectum). Polyps reported on CCE but not found by colonoscopy were regarded as false negative for colonoscopy. Polyps found by colonoscopy but not found by CCE were regarded as false negative for CCE. Thus, the standard used here to determine colonoscopy and CCE per-polyp sensitivity in patients undergoing both investigations was the sum of matched and unmatched polyps in both investigations. Proportions are reported with 95% confidence intervals and compared using the chi-square test. A P-value of < 0.05 was considered statistically significant. STATA 15 (StataCorp LLC, College Station, TX, USA) was used for analysis.
Results
A total of 180 patients were included. Their mean age was 59 years and 52% were men. The indication for surveillance and time since last colonoscopy are shown in Table 1 . Forty-one per cent of patients had surveillance due to a family history of CRC, and 59% had surveillance due to a personal history of adenomas. The majority (90.5%) had had their last colonoscopy within 3 years. The CCE excretion rate was 70.6% and the rate of adequate cleansing was 92.2%, resulting in a complete examination rate for CCE of 66.7%. The polyp detection rate in complete CCE exams was 69%.
The flow of patients according to the study protocol is shown in Fig. 1 . A total of 77 patients (42.8%) had a complete CCE with fewer than three polyps < 10 mm. They were scheduled for their next follow-up. The remaining 103 patients (57.2%) with either a complete CCE with findings above the threshold (n = 43, 23.9%) or an incomplete CCE (n = 60, 33.3%) underwent conventional endoscopy in order to remove detected polyps or for diagnostic purposes. Of those, 36 (20%) underwent sigmoidoscopy, 65 (36.1%) underwent colonoscopy and 2 (1.1%) were referred for endoscopic mucosal resection due to larger lesions. Table 2 lists the findings of the subsequent conventional endoscopy. The polyp detection rate was 55.3% and the adenoma detection rate 42.7%. Fifty-nine patients (57.3%) had no adenomas detected, 33 (32.0%) had 'low-risk' adenomas and 11 (10.7%) 'high-risk' adenomas. Table 3 summarizes the 29 patients who had a complete CCE and a full colonoscopy. Sixty polyps were matched between CCE and colonoscopy. CCE detected an additional 60 polyps and colonoscopy detected an additional 16 polyps that could not be matched between the two exams. The resulting per-polyp sensitivity was 88% (95% CI 82.8-93.6%) for CCE and 56% (47.6-64.2%) for colonoscopy (P < 0.0001) when regarding all polyps found in both examinations to be true positive findings. Out of the 60 polyps detected by CCE and not matched by colonoscopy, 13 were ≥ 10 mm. Images of these polyps are shown in Fig. 2 . All 16 polyps found by colonoscopy not matched with CCE were sub-centimetre polyps: nine were hyperplastic polyps and seven were tubular adenomas with low-grade dysplasia.
Discussion
The use of CCE as a filter in colonic surveillance has several challenges. Firstly, we found a complete CCE examination rate of 66.7%, meaning that one-third of the patients had to undergo an additional examination for diagnostic purposes. Secondly, the polyp detection rate of 69% in complete examinations indicates a high rate of polyps in this group, but only half of the polyps detected by CCE in the patients referred for colonoscopy could be found and removed. In a recent trial on CRC screening patients we found a higher polyp detection rate of 86% in complete exams, and a similar trend of CCE reporting more polyps than colonoscopy [8] .
Using a cut-off of no more than two small (< 10 mm) polyps (no polyps at all for HNPCC patients), we found that 42.8% needed no further investigation during the current surveillance and were scheduled for their next follow-up within 1-5 years. An additional 20% could be completed with a sigmoidoscopy and only 37.2% required a full colonoscopy. Still, only 10.7% of patients undergoing endoscopy had high-risk findings. This indicates that due to the low yield of colonoscopic surveillance the potential for filtering patients using CCE is substantial, but it implies that small polyps are left untreated until the subsequent follow-up. Whether the approach of leaving small polyps behind is safe or not is debatable, and knowledge about this is scarce. In a recent review [11] of nine studies, 721 patients and 1034 diminutive or small adenomas, 6% progressed to advanced adenomas over time. Disregarding of diminutive and small polyps is currently practised with CT colonography in most countries. With the known high rate of missed polyps by colonoscopy [12] , the higher sensitivity of CCE [8] , the low incidence of advanced neoplasia in small polyps and the slow growth rate of small polyps [13, 14] , the risk of this approach compared with current practice seems negligible, if not favourable (especially in this surveillance setting where most patients have undergone colonoscopy within the last 3 years and are expected to undergo another within the next 5 years). Results from this trial, when the next surveillance has been done, will help to shed light on the risk of leaving polyps behind.
In all previous trials comparing CCE and colonoscopy, any polyps that could not be confirmed by colonoscopy were regarded as false positive for CCE. Sometimes, due to multiple passages and reporting of the same polyp several times, this will also be the case. But, as has been shown, colonoscopy may also miss polyps. In this trial, colonoscopists were not blinded to the CCE report and were thus given a better opportunity to find the polyps reported in CCE. Still, in the 29 patients who underwent two complete investigations, 60 polyps reported in CCE could not be found. When all polyps found by both methods are regarded as true, this leads to a superior sensitivity of CCE compared with colonoscopy. This is a very small population for the testing of diagnostic accuracy, and it is probably an overestimation. It illustrates the statistical significance of how the gold standard is defined, but also the clinical dilemma involved when CCE is used as a filter and not all the detected polyps can be accounted for at the subsequent colonoscopy.
Another important issue regarding the implementation of CCE into clinical practice is the workload associated with the procedure and its cost-effectiveness. Currently, an investigator needs approximately 1 h to evaluate the video and devise the report. This time is longer than that needed with most colonoscopies. Further, with only one marketed solution, the price of the hardware remains high and the total cost of the procedure is approximately twice that of a colonoscopy. Clearly, as of yet, the CCE procedure is not cost-effective, but this may change as more solutions are marketed and artificial intelligence is developed for video analyses. Our research unit is currently developing machine learning algorithms for assessment of bowel cleansing [15] , polyp recognition and polyp localization (papers submitted).
The CCE completion rate using low-volume and low-risk preparations and booster compounds needs to be improved before CCE can be implemented into clinical practice as a diagnostic alternative to CT-colonography and colonoscopy. Even if the procedure can be improved, there remain clinical issues regarding the need to leave polyps behind when using CCE as a filter, but also when the polyps cannot be found at the subsequent colonoscopy. If other noninvasive testing such as Figure 2 Images of the 13 polyps ≥ 10 mm that were detected by colon capsule endoscopy but not retrieved by colonoscopy.
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